DNER and diffuse large B-cell lymphoma: These results suggested that the anti-DLBCL effects of YLT-LL-11 might be associated with G0/G1 phase arrest, which is consistent with the effect of well-known BET inhibitors JQ1 in a panel of leukemia and lymphoma cell lines [27,29,30].